0 CHECKOUT
Predictive Diagnostics - Global Strategic Business Report Product Image

Predictive Diagnostics - Global Strategic Business Report

  • ID: 2692229
  • April 2015
  • Region: Global
  • 175 Pages
  • Global Industry Analysts, Inc

This report analyzes the worldwide markets for Predictive Diagnostics in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020.

Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

The report profiles 49 companies including many key and niche players such as -

- Abbott Molecular
- Almac Group Ltd.
- BioGenex
- Covance, Inc.
- Dako Denmark A/S

Note: Product cover images may vary from those shown

PREDICTIVE DIAGNOSTICS

A GLOBAL STRATEGIC BUSINESS REPORT

CONTENTS

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW
A Curtain Raiser
Predictive Diagnostics
A Key Segment of Genetic Testing
Outlook for Predictive Diagnostics Market

2. MAJOR MARKET TRENDS, DRIVERS, AND ISSUES
Prospects for Predictive Genetic Diagnostics Grow Brighter
Increasing Incidence and Prevalence of CDDs: A Major Growth Driver
Diagnosed Cases of Cancer on the Rise
Table 1: Worldwide Incidence of Cancer in Million: 2012, 2020 & 2030 (includes corresponding Graph/Chart)
Table 2: World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported (in Thousands) for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)
Table 3: New Cancer Cases in the World by Affected Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
Table 4: Global Cancer Incidence by Income Group: 2012 (in Thousands) (includes corresponding Graph/Chart)
Predictive Diagnostics
Crucial for Breast Cancer Management
Table 5: World Breast Cancer Statistics: Top 20 Countries with Highest Breast Cancer Rates (includes corresponding Graph/Chart)
Incidence of Neurodegenerative Diseases Increasing
Alzheimer’s Disease
Huntington’s Disease
Quick Facts on the Global Prevalence of Huntington's Disease
Parkinson’s Disease
Ballooning Global Population Offers Significant Growth Opportunities
Table 6: Top 25 Countries Worldwide in Terms of Population (2015E) (includes corresponding Graph/Chart)
Predictive Diagnostics Enable Higher Life Expectancy
Table 7: Life Expectancy at Age 60 and 80 Years
(2010-2015), (2020-2025) & (2045-2050) (includes corresponding Graph/Chart)
Table 8: Global Population Statistics for the 65+ Age Group: 2013 (includes corresponding Graph/Chart)
Table 9: Global 60+ Years Population as a Percentage of Total Population by Geographic Region (2013) (includes corresponding Graph/Chart)
Table 10: Global Aging Population (2013): Population in the Age Groups 60-64, 65-79 and 80 above as a Percentage of Total Population by Major Geographic Regions (includes corresponding Graph/Chart)
Pharmacogenomics Development Augurs Growth of Predictive Diagnostics
Discovery of Novel Biomarkers
Crucial to Predictive Diagnostics
Next-Generation Sequencing
A Giant Leap in Genome Sequencing
Breast Cancer Gene Testing Market to Expand Strongly
Myriad Genetics
The Unquestioned Leader in Breast Cancer Testing
Growing Direct-to-Consumer Genetic Testing: Boon or Bane??
Genomic Research Remains Confined to Fundamental Research
Unresolved Issues Hamper Widespread Implementation of Genetic Diagnosis and Testing for Monogenetic Disease
Dearth of Genetic Counselors
A Major Hurdle for the Predictive Genetic Testing
Framework for Validation, Regulation, and Ethical Issues
The Need of the Hour

3. PRODUCT OVERVIEW
Introduction
Underlying Principles of Predictive Diagnostics
Predictive Diagnostics Vis-a-vis Conventional Testing
Characteristics of an Effective Predictive Diagnostic Test
Applications of Predictive Diagnostics
Pre-Symptomatic
Predisposition Testing
Cancer Testing
Carrier Identification
Pharmacogenetics
Pharmacogenomics
Prenatal Diagnosis
Steps in Genetic Testing Process
Limitations
Risks and Other Limitations of Genetic Testing
Select Diseases Identified Using Predictive Diagnostics
Cystic Fibrosis
Breast and Ovarian Cancer (BRCA)
Alzheimer's Disease
Colorectal Cancer
Hemochromatosis (HH)
Huntington's Disease (HD)
Costs of Select Tests
Table 11: Costs of Select Genetic Tests
Medical Ethics Surrounding Predictive Diagnostics

4. PRODUCT INTRODUCTIONS
Genomic Health Reports Positive Clinical Study Results of Oncotype DX Test
Genetic Technologies Limited Launches BREVA Genplus
Myriad Genetics Reports Positive Trial Results for MyRisk Diagnostic Test
SRL Diagnostics Launches ST2 Test to Predict Heart Failure
ColDx Assay by Almac Validated as Colon Cancer Biomarker
LabCorp. Launches Several Cancer Assays
MolecularMD Develops and Validates Assay Tests to Determine LKB1 Expression and Mutation Status
Abbott's Galectin-3 Assay Awarded CE Marking
Asuragen Introduces BRAF and KRAS Mutation Testing Services

5. RECENT INDUSTRY ACTIVITY
MedImmune Completes Acquisition of Definiens
LabCorp. to Acquire Covance
Myriad to Market EndoPredict Test by Sividon Diagnostics
QIAGEN Takes Over Ingenuity Systems
Cenix to Partner with Debiopharm
MolecularMD Corp. Obtains License for LKB1 Gene Technology
Agilent Acquires Dako
Celgene Takes Over Avila Therapeutics
Signal Genetics Acquires ChipDX
Roche and Med Fusion Form Strategic Alliance
Epistem Inks Supply and Distribution Agreement with Becton Dickinson for Tuberculosis Test
Rosetta Genomics Signs Co-Marketing Agreement with Precision Therapeutics
Quintiles Establishes Oxford Cancer Biomarkers for Personalized Medicine Care
Cornell University Licenses microRNA Diagnostic IP to Prolias Technologies
Signal Genetics Introduces ResultsPX™ Analysis Tool and Physician Web Portal for Genetic Test Results

6. FOCUS ON SELECT KEY PLAYERS
Abbott Molecular (US)
Almac Group Ltd. (Ireland)
BioGenex (US)
Covance, Inc. (US)
Dako Denmark A/S (Denmark)
Epistem Plc. (UK)
F. Hoffmann-La Roche Ltd. (Switzerland)
Genomic Health, Inc. (US)
MDxHEALTH, Inc. (US)
Myriad Genetics, Inc. (US)
Precision Therapeutics, Inc. (US)
Prometheus Laboratories (US)
QIAGEN N.V. (The Netherlands)

7. GLOBAL MARKET PERSPECTIVE
Table 12: World Recent Past, Current & Future Analysis for Predictive Diagnostics by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 13: World Historic Review for Predictive Diagnostics by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2013 (includes corresponding Graph/Chart)
Table 14: World 12-Year Perspective for Predictive Diagnostics by Geographic Region
Percentage Breakdown of Dollar Revenues for US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets for the Years 2009, 2015 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES
A.Market Analysis
Market Outlook
Genetic Information Nondiscrimination Act (GINA) Boosts Genetic Testing
High Frequency of Predictive CFTR Screening in Expectant Mothers
Cancer Stats
Opportunity Indicator
Table 15: New Cancer Cases in the US by Gender and Affected Site: 2014E(includes corresponding Graph/Chart)
Table 16: Incidence of Cancer for All Body Sites by Gender & Age Group in the US (2013): New Cancer Cases for Males & Females for the Age groups Under 45 years; 45 years and Above; Under 65 years; 65 years and Above (includes corresponding Graph/Chart)
Table 17: The US Breast Cancer Incidence in Women by State (2013): New Cases of Breast Cancer in Leading 15 States (includes corresponding Graph/Chart)
Product Introductions
Strategic Corporate Developments
Select Key Players
B.Market Analytics
Table 18: The US Recent Past, Current & Future Analysis for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 19: The US Historic Review for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2013 (includes corresponding Graph/Chart)

2. CANADA
A.Market Analysis
Cancer Statistics in Canada: Opportunity Indicator
Table 20: New Cancer Cases in Canada by Gender and Affected Site: 2014E (includes corresponding Graph/Chart)
Table 21: New Cancer Cases in Canada by Province: 2014E (includes corresponding Graph/Chart)
Table 22: New Cancer Cases in Canada by Age Group: 2014E (includes corresponding Graph/Chart)
B.Market Analytics
Table 23: Canadian Recent Past, Current & Future Analysis for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 24: Canadian Historic Review for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2013 (includes corresponding Graph/Chart)

3. JAPAN
Market Analysis
Table 25: Japanese Recent Past, Current & Future Analysis for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 26: Japanese Historic Review for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2013 (includes corresponding Graph/Chart)

4. EUROPE
A.Market Analysis
Predictive Testing to Dominate Genetic Testing and Screening Services in Europe
Table 27: European Genetic Testing Market by Type (2014 & 2018E): Percentage Breakdown of Diagnostic, Predictive, and Relationship Testing Revenue (includes corresponding Graph/Chart)
Hassles Faced by European Genetic Testing Market
Cancer Statistics in Europe
Table 28: Number of New Cancer Cases in Europe: 2012-2030 (includes corresponding Graph/Chart)
B.Market Analytics
Table 29: European Recent Past, Current & Future Analysis for Predictive Diagnostics by Geographic Region
France, Germany, Italy, UK, and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 30: European Historic Review for Predictive Diagnostics by Geographic Region
France, Germany, Italy, UK, and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2013 (includes corresponding Graph/Chart)
Table 31: European 12-Year Perspective for Predictive Diagnostics by Geographic Region
Percentage Breakdown of Dollar Revenues for France, Germany, Italy, UK, and Rest of Europe Markets for the Years 2009, 2015 & 2020 (includes corresponding Graph/Chart)
4a. FRANCE
Market Analysis
Table 32: French Recent Past, Current & Future Analysis for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 33: French Historic Review for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2013 (includes corresponding Graph/Chart)
4b. GERMANY
A.Market Analysis
German Ethics Council Releases Recommendations for Genetic Testing
Proposals Mentioned: A Snapshot
Strategic Corporate Development
IMGM Laboratories GmbH
A Key Player
B.Market Analytics
Table 34: German Recent Past, Current & Future Analysis for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 35: German Historic Review for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2013 (includes corresponding Graph/Chart)
4c. ITALY
Market Analysis
Table 36: Italian Recent Past, Current & Future Analysis for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 37: Italian Historic Review for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2013 (includes corresponding Graph/Chart)
4d. THE UNITED KINGDOM
A.Market Analysis
Current and Future Analysis
UK Government Encourages Genetic Testing
Epistem Plc
A Key Player
B.Market Analytics
Table 38: The UK Recent Past, Current & Future Analysis for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 39: The UK Historic Review for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2013 (includes corresponding Graph/Chart)
4e. REST OF EUROPE
A.Market Analysis
Strategic Corporate Developments
Select Key Players
B.Market Analytics
Table 40: Rest of European Recent Past, Current & Future Analysis for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 41: Rest of European Historic Review for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2013 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC
A.Market Analysis
Table 42: Population Statistics in Asia (Including Japan) & Percentage of Population Aged Above 65 Years (includes corresponding Graph/Chart)
B.Market Analytics
Table 43: Asia-Pacific Recent Past, Current & Future Analysis for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 44: Asia-Pacific Historic Review for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2013 (includes corresponding Graph/Chart)

6. REST OF WORLD
A.Market Analysis
Product Introductions
Strategic Corporate Developments
Emsurg Healthcare (India) Pvt. Limited
A Key Player
B.Market Analytics
Table 45: Rest of World Recent Past, Current & Future Analysis for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 46: Rest of World Historic Review for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2013 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 49 (including Divisions/Subsidiaries - 51)

The United States (24)
Canada (1)
Europe (17)
- Germany (4)
- The United Kingdom (5)
- Spain (1)
- Rest of Europe (7)
Asia-Pacific (Excluding Japan) (7)
Middle East (2)

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-5 user licence, allowing up to five users have access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-10 user licence, allowing up to ten users have access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-15 user licence, allowing up to fifteen users have access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • bioCSL
  • Abbott Laboratories Ltd.
  • Radiometer Limited
  • Genfit
  • Focus Diagnostics Inc.
  • Genomic Health Inc.